Impact of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on intracranial atherosclerotic plaque characteristics and low density lipoprotein-cholesterol (LDL-C) reduction: a real-world observational study
前蛋白转化酶枯草杆菌蛋白酶/kexin 9型(PCSK9)抑制剂对颅内动脉粥样硬化斑块特征和低密度脂蛋白胆固醇(LDL-C)降低的影响:一项真实世界观察性研究
期刊:PeerJ
影响因子:2.4
doi:10.7717/peerj.20668
Li, Zhenzhen; Li, Xiaohui; Zhang, Yiting; Qi, Jingwen; Ji, Lifan; Li, Shuo; Gu, Mengmeng; Liu, Yukai; Zhang, Yuqiao; Mei, Yanping; Wang, Meng; Zhou, Junshan; Su, Mouxiao; Zhu, Lin; Deng, Qiwen